Greenway Medical Technologies Inc Sample Contracts

Greenway Medical Technologies Inc – AMENDED AND RESTATED BY-LAWS OF GREENWAY MEDICAL TECHNOLOGIES, INC. (November 4th, 2013)
Greenway Medical Technologies Inc – NEWS RELEASE (November 4th, 2013)

Carrollton, GA and Tampa, FL — Nov. 4, 2013 — Vitera Healthcare Solutions, LLC and Greenway Medical Technologies, Inc., leading providers of clinical, financial and administrative solutions to healthcare providers, today announced the completion of a previously announced merger resulting in the combination of the two companies into an innovative leader in health information technology.

Greenway Medical Technologies Inc – AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF GREENWAY MEDICAL TECHNOLOGIES, INC. (November 4th, 2013)

The address of the Corporation’s registered office in the State of Delaware is 1209 Orange Street, in the City of Wilmington, County of New Castle, Delaware, 19801. The name of its registered agent at such address is The Corporation Trust Company.

Greenway Medical Technologies Inc – NEWS RELEASE (September 23rd, 2013)

Carrollton, GA, and Tampa, FL, September 23, 2013 — Greenway Medical Technologies, Inc. (NYSE: GWAY) today announced a definitive agreement which will result in the combination of the businesses of Greenway and Vitera Healthcare Solutions, LLC. The transaction will create a leader in healthcare information technology and services, offering a comprehensive set of solutions to improve clinical and financial outcomes in healthcare enterprises, ambulatory practices, public health, retail and other clinics nationwide. Following the closing of the transaction, the Vitera and Greenway businesses will serve nearly 13,000 medical organizations and 100,000 providers.

Greenway Medical Technologies Inc – AGREEMENT AND PLAN OF MERGER among: Greenway Medical Technologies, Inc., (September 23rd, 2013)

This Agreement and Plan of Merger (“Agreement”) is made and entered into as of September 23, 2013, by and among: VCG Holdings, LLC, a Delaware limited liability company (“Parent”); Crestview Acquisition Corp, a Delaware corporation and a wholly owned direct subsidiary of Parent (“Merger Sub”); and Greenway Medical Technologies, Inc., a Delaware corporation (the “Company”). Certain capitalized terms used in this Agreement are defined in Exhibit A.

Greenway Medical Technologies Inc – FOURTH AMENDMENT TO CREDIT AGREEMENT (September 13th, 2013)

THIS FOURTH AMENDMENT TO CREDIT AGREEMENT (this “Amendment”) is made and entered into as of June 10, 2013, by and between GREENWAY MEDICAL TECHNOLOGIES, INC., a Georgia corporation, as the borrower (the “Borrower”), each of the

Greenway Medical Technologies Inc – THIRD AMENDMENT TO CREDIT AGREEMENT (September 13th, 2013)

THIS THIRD AMENDMENT TO CREDIT AGREEMENT (this “Amendment”) is made and entered into as of March 14, 2013, by and between GREENWAY MEDICAL TECHNOLOGIES, INC., a Georgia corporation, as the borrower (the “Borrower”), each of the lenders party hereto (collectively, the “Lenders”), and BANK OF AMERICA, N.A., a national banking association, as the administrative agent (together with its successors and assigns, the “Administrative Agent”).

Greenway Medical Technologies Inc – NEWS RELEASE (April 30th, 2013)

April 29, 2013, Carrollton, GA — Based on its preliminary results for the third quarter of fiscal 2013 as well as its estimates for the fiscal fourth quarter, Greenway Medical Technologies, Inc. (NYSE: GWAY), is revising its previously issued outlook for its 2013 fiscal year that will end June 30, 2013, to include expected revenue of $132 million to $134 million, and adjusted EBITDA of $5.8 million to $6.8 million. Greenway delivers innovative software and business service solutions for healthcare providers through its PrimeSUITE® platform.

Greenway Medical Technologies Inc – NEWS RELEASE (April 29th, 2013)

April 29, 2013, Carrollton, GA — Based on its preliminary results for the third quarter of fiscal 2013 as well as its estimates for the fiscal fourth quarter, Greenway Medical Technologies, Inc. (NYSE: GWAY), is revising its previously issued outlook for its 2013 fiscal year that will end June 30, 2013, to include expected revenue of $132 million to $134 million, and adjusted EBITDA of $5.8 million to $6.8 million. Greenway delivers innovative software and business service solutions for healthcare providers through its PrimeSUITE® platform.

Greenway Medical Technologies Inc – CONFIDENTIAL CONFIDENTIAL TREATMENT REQUESTED. CONFIDENTIAL PORTIONS OF THIS DOCUMENT HAVE BEEN REDACTED AND HAVE BEEN SEPARATELY FILED WITH THE COMMISSION. (September 28th, 2012)

· The entry point into the plan for the bookings related Company Financial Goals begins when bookings achievement is at least 90% of targeted levels and EBITDA (after all bonus payments) is at least $15M. The bonus payment for the sales bookings-related Company Financial Goals is based on actual sales bookings as a percentage of targeted sales margin:

Greenway Medical Technologies Inc – NEWS RELEASE For more information, contact: Al Cochran, Chief Financial Officer, (678) 839-5860, alcochran@greenwaymedical.com Bob Kneeley, Vice President, Investor Relations, (678) 390-7262, bobkneeley@greenwaymedical.com (August 29th, 2012)

August 29, 2012, Carrollton, Ga. – Greenway Medical Technologies, Inc. (NYSE: GWAY), which delivers innovative software and business services solutions for ambulatory care providers through its PrimeSUITE® platform, today announced record financial results for the three and 12 months ended June 30, 2012.

Greenway Medical Technologies Inc – NEWS RELEASE (May 10th, 2012)

May 10,2012, Carrollton, Ga. – Greenway Medical Technologies, Inc. (NYSE: GWAY), provider of the integrated electronic health record (EHR), practice management and interoperability solution PrimeSUITE®, today announced its financial results for the three and nine months ended March 31, 2012.

Greenway Medical Technologies Inc – NEWS RELEASE For more information, contact: Al Cochran, Chief Financial Officer, (678) 839-5860, alcochran@greenwaymedical.com (March 13th, 2012)

March 13, 2012, Carrollton, Ga. – Greenway Medical Technologies, Inc. (NYSE: GWAY), provider of the integrated electronic health record (EHR), practice management and interoperability solution PrimeSUITE®, today announced its financial results for the three and six months ended December 31, 2011.

Greenway Medical Technologies Inc – CONFIDENTIAL CONFIDENTIAL TREATMENT REQUESTED. CONFIDENTIAL PORTIONS OF THIS DOCUMENT HAVE BEEN REDACTED AND HAVE (March 5th, 2012)
Greenway Medical Technologies Inc – GREENWAY MEDICAL TECHNOLOGIES, INC. 2011 STOCK PLAN Stock Option Award Agreement (March 5th, 2012)

This Award is conditioned on your execution of this Award Agreement within twenty (20) days after the Grant Date specified in Section 1 below. By executing this Award Agreement, you will be irrevocably agreeing that all of your rights under this Award will be determined solely and exclusively by reference to the terms and conditions of the Plan, subject to the provisions set forth below. As a result, you should not execute this Award Agreement until you have (i) carefully considered the terms and conditions of the Plan and this Award (including all of the attached Exhibits), and (ii) consulted with your personal legal and tax advisors about all of these documents.

Greenway Medical Technologies Inc – SECOND AMENDMENT TO AND CONSENT UNDER CREDIT AGREEMENT (January 18th, 2012)

THIS SECOND AMENDMENT TO AND CONSENT UNDER CREDIT AGREEMENT (this “Amendment”) is made and entered into as of December 1, 2011, by and between GREENWAY MEDICAL TECHNOLOGIES, INC., a Georgia corporation, as the borrower (the “Borrower”), each of the lenders party hereto (collectively, the “Lenders”), and BANK OF AMERICA, N.A., a national banking association, as the administrative agent (together with its successors and assigns, the “Administrative Agent”).

Greenway Medical Technologies Inc – GREENWAY MEDICAL TECHNOLOGIES, INC. FORM OF INDEMNIFICATION AGREEMENT (January 18th, 2012)

This Indemnification Agreement (this “Agreement”) is effective as of , 2012 by and between Greenway Medical Technologies, Inc., a Delaware corporation (the “Company”), and ____________ (the “Indemnitee”).

Greenway Medical Technologies Inc – GREENWAY MEDICAL TECHNOLOGIES, INC. 2004 STOCK PLAN (January 18th, 2012)

WHEREAS, Greenway Medical Technologies, Inc. (the “Company”) maintains the Greenway Medical Technologies, Inc. 2004 Stock Plan (the “Plan”), and Section 11(b) of the Plan permits the Company’s Board of Directors (the “Board”) to amend the Plan at any time; and

Greenway Medical Technologies Inc – GREENWAY MEDICAL TECHNOLOGIES, INC. 2011 STOCK PLAN (January 18th, 2012)
Greenway Medical Technologies Inc – GREENWAY MEDICAL TECHNOLOGIES, INC. BYLAWS (January 18th, 2012)
Greenway Medical Technologies Inc – CERTIFICATE OF INCORPORATION OF (January 18th, 2012)

The address of the registered office of the Corporation in the State of Delaware is the Corporation Trust Center, 1209 Orange Street, Wilmington, Delaware, 19801, in the County of New Castle. The name of the registered agent at that address is The Corporation Trust Company.

Greenway Medical Technologies Inc – GREENWAY MEDICAL TECHNOLOGIES, INC. _______________ Shares of Common Stock (Par Value $0.0001 Per Share) Form of Underwriting Agreement (January 18th, 2012)
Greenway Medical Technologies Inc – Compensation Plan 2011 (January 18th, 2012)

The entry point into the plan for the bookings related Company Financial Goals begins when bookings achievement is at least 90% of targeted levels and EBITDA (after all bonus payments) is at least $5.0M. The bonus payment for the sales bookings-related Company Financial Goals is based on actual sales bookings as a percentage of targeted sales margin:

Greenway Medical Technologies Inc – GREENWAY MEDICAL TECHNOLOGIES, INC. CODE OF BUSINESS CONDUCT AND ETHICS FOR EMPLOYEES, OFFICERS AND DIRECTORS (January 18th, 2012)

This Code cannot possibly describe every practice or principle related to honest and ethical conduct. The Code addresses conduct that is particularly important to proper dealings with the people and entities with whom Greenway interacts, but reflects only a part of Greenway’s commitment. From time to time Greenway may adopt additional policies and procedures with which Greenway’s employees, officers and directors are expected to comply, if applicable to them. However, it is the responsibility of each employee to apply common sense, together with his or her own highest personal ethical standards, in making business decisions where there is no stated guideline in the Code.

Greenway Medical Technologies Inc – CONFIDENTIAL CONFIDENTIAL TREATMENT REQUESTED. CONFIDENTIAL PORTIONS OF THIS DOCUMENT HAVE BEEN REDACTED AND HAVE BEEN SEPARATELY FILED WITH THE COMMISSION. (December 5th, 2011)

The entry point into the plan for the bookings related Company Financial Goals begins when bookings achievement is at least 90% of targeted levels and EBITDA (after all bonus payments) is at least $5.0M. The bonus payment for the sales bookings-related Company Financial Goals is based on actual sales bookings as a percentage of targeted sales margin:

Greenway Medical Technologies Inc – FIRST AMENDMENT TO, LIMITED WAIVER AND CONSENT UNDER CREDIT AGREEMENT (December 5th, 2011)

THIS FIRST AMENDMENT TO, LIMITED WAIVER AND CONSENT UNDER CREDIT AGREEMENT (this “Amendment”) is made and entered into as of September 23, 2011, by and between GREENWAY MEDICAL TECHNOLOGIES, INC., a Georgia corporation, as the borrower (the “Borrower”), each of the lenders party hereto (collectively, the “Lenders”), and BANK OF AMERICA, N.A., a national banking association, as the administrative agent (together with its successors and assigns, the “Administrative Agent”).

Greenway Medical Technologies Inc – CONFIDENTIAL (December 5th, 2011)

This Software License and Services Agreement (the “Agreement”) is made and entered into as of the date of the last signature below (“Effective Date”) by and between GREENWAY MEDICAL TECHNOLOGIES, INC., a Georgia corporation having its principal place of business at 121 Greenway Boulevard, Carrollton, Georgia 30117 (“Greenway”) and WALGREEN CO., an Illinois corporation with offices located at 200 Wilmot Rd, Deerfield, Illinois 60015, on behalf of itself, and its Subsidiaries as defined herein (“Client”).

Greenway Medical Technologies Inc – CONFIDENTIAL (September 23rd, 2011)

• The entry point into the plan for the bookings related Company Financial Goals begins when bookings achievement is at least 90% of targeted levels and EBITDA (after all bonus payments) is at least $[CONFIDENTIAL MATERIAL REDACTED AND FILED SEPARATELY WITH THE COMMISSION]. The bonus payment for the sales bookings-related Company Financial Goals is based on actual sales bookings as a percentage of targeted sales margin:

Greenway Medical Technologies Inc – AMENDED AND RESTATED ARTICLES OF INCORPORATION OF GREENWAY MEDICAL TECHNOLOGIES, INC. (September 23rd, 2011)

Greenway Medical Technologies, Inc., a corporation organized and existing under and by virtue of the provisions of the Georgia Business Corporation Code does hereby certify:

Greenway Medical Technologies Inc – CONFIDENTIAL (September 23rd, 2011)

This Software License and Services Agreement (the “Agreement”) is made and entered into as of the date of the last signature below (“Effective Date”) by and between GREENWAY MEDICAL TECHNOLOGIES, INC., a Georgia corporation having its principal place of business at 121 Greenway Boulevard, Carrollton, Georgia 30117 (“Greenway”) and WALGREEN CO., an Illinois corporation with offices located at 200 Wilmot Rd, Deerfield, Illinois 60015, on behalf of itself, and its Subsidiaries as defined herein (“Client”).

Greenway Medical Technologies Inc – Greenway Medical Technologies, Inc. 2004 Stock Plan (August 26th, 2011)

You have been granted the following option to purchase shares of the Common Stock of Greenway Medical Technologies, Inc. (the “Company”):

Greenway Medical Technologies Inc – CREDIT AGREEMENT Dated as of March 22, 2011 among GREENWAY MEDICAL TECHNOLOGIES, INC. as Borrower, BANK OF AMERICA, N.A., as Administrative Agent and LC Issuer, and The Other Lenders Party Hereto (August 26th, 2011)

CREDIT AGREEMENT (this “Agreement”) is entered into as of March 22, 2011, among GREENWAY MEDICAL TECHNOLOGIES, INC., a Georgia corporation (“Borrower”), each lender from time to time party hereto (collectively, “Lenders” and individually, a “Lender”), and BANK OF AMERICA, N.A., as Administrative Agent and L/C Issuer.

Greenway Medical Technologies Inc – GREENWAY MEDICAL TECHNOLOGIES 1999 STOCK OPTION PLAN (August 26th, 2011)
Greenway Medical Technologies Inc – SECOND AMENDED AND RESTATED VOTING AGREEMENT (August 26th, 2011)

This SECOND AMENDED AND RESTATED VOTING AGREEMENT (the “Agreement”) is made and entered into effective as of October __, 2006, by and among Greenway Medical Technologies, Inc., a Georgia corporation (the “Company”), the holders of the Company’s Series A Preferred Stock (the “Series A Preferred Stock”) listed on Schedule A hereto (collectively, the “Series A Investors”), the holders of the Company’s Series B Preferred Stock (the “Series B Preferred Stock” and together with the Series A Preferred Stock, the “Preferred Stock”) listed on Schedule B hereto (collectively, the “Series B Investors”), and the holders of Common Stock of the Company listed on Schedule C hereto (collectively, the “Common Holders”). The Company, the Series A Investors, the Common Holders and the Series B Investors are individually referred to herein as a “Party” and are collectively referred to herein as the “Parties.” The Company’s Board of Directors is referred to herein as the “Board.”

Greenway Medical Technologies Inc – GREENWAY MEDICAL TECHNOLOGIES, INC. 2004 STOCK PLAN (August 26th, 2011)